Insulin Therapies for Diabetes: Evidence and Outcomes

View Evidence Brief

Evidence on outcomes studied for Insulin Therapies

Evidence related to insulin therapies in diabetes studies.

Build your Evidence Workspace

Save evidence about the topics you care about.

Studies

Evidence Pairs

Moderate Evidence

Evidence Strength: 62/100

Evidence Intelligence™

Evidence Summary

A structured summary of where the evidence is strongest, mixed, or still emerging.

Executive Summary

Insulin Therapies evidence appears to center on HbA1c.

Among 23 indexed studies and 4 interventions, the strongest signals are summarized from the available evidence. HbA1c appears to be one of the clearer current evidence signals.

Evidence is consistently positive across multiple studies.
Some evidence is positive, but results are not consistent across all studies.
Early findings are encouraging, but stronger trials are needed.

Caution

This summary reflects the currently indexed evidence and should not be interpreted as treatment advice.

Key Finding

Evidence is consistently positive across multiple studies.

Interventions with strongest consistent evidence

Strongest consistent evidence

Why it matters

Consistent positive findings are easier to interpret than isolated or mixed results.

Interpretation

HbA1c appears to have a consistent beneficial signal in the indexed evidence.

View supporting studies

Evidence basis: 10 evidence pairs - 17 studies

Why this appears here

Strong evidenceConsistent resultsPositive effect signalMultiple RCTsModerate evidenceGenerally consistent

HbA1c

13 studies

EvidenceScore™

79/100

ConsistencyScore™

75/100

Total daily insulin dose

4 studies

EvidenceScore™

69/100

ConsistencyScore™

100/100

Evidence Snapshot

Studies

Interventions

Outcomes

Across 3 studies, Insulin therapy shows a evidence signal for Hypoglycemia events.

3 studies

EvidenceScore™: 79/100

View supporting studies

Supporting Evidence

Mixed or conflicting evidence

Some evidence is positive, but results are not consistent across all studies.

Areas where results are mixed

Why it matters

Mixed results suggest effects may depend on population, comparator, duration, or study design.

Interpretation

HbA1c is mixed in the currently indexed evidence.

Caution

Some supporting studies reported neutral, negative, or mixed findings.

Top entities

HbA1c

Time in range

HbA1c

13 studies

EvidenceScore™

79/100

ConsistencyScore™

75/100

Why this appears here

Mixed Or Conflicting ResultsPositive Signal PresentNeutral Results PresentNegative Results Present

Evidence basis: 12 evidence pairs - 20 studies

View supporting studies

Promising but understudied

Early findings are encouraging, but stronger trials are needed.

Promising areas needing more evidence

Why it matters

Promising signals can guide further review, but they should not be treated as settled evidence.

Interpretation

Glucose iAUC (OGTT) may have a beneficial signal, but the evidence base is still developing.

Caution

Current support is limited by study volume, RCT depth, or evidence strength.

Top entities

Glucose iAUC (OGTT)

Hypoglycemia events

Glucose iAUC (OGTT)

3 studies

EvidenceScore™

79/100

ConsistencyScore™

52/100

Why this appears here

Positive effect signalLimited study volume

Evidence basis: 8 evidence pairs - 11 studies

View supporting studies

Question Highlights

Quick answers to the most important questions supported by the available evidence.

Explore all evidence questions

What outcomes has Insulin Therapies been studied for?

HbA1c, Glucose iAUC (OGTT), and Hypoglycemia events are among the most studied areas in relation to Insulin Therapies.

HbA1c, Glucose iAUC (OGTT), and Hypoglycemia events are among the best-supported options in the available evidence across 23 studies.

The evidence includes both beneficial and harmful or worsening results.

View full answer

Does Insulin Therapies improve HbA1c?

Insulin Therapies may improve HbA1c.

Strong evidence is based on 13 supporting studies.

Population details are unavailable.

View full answer

How does Insulin Therapies compare across studied outcomes?

HbA1c, Glucose iAUC (OGTT), and Hypoglycemia events have available evidence for Insulin Therapies, but the comparison requires review of the underlying studies.

Evidence is available for both Glucose iAUC (OGTT) and HbA1c; the underlying studies are needed for a direct comparison.

The evidence includes both beneficial and harmful or worsening results.

View full answer

Explore all evidence questions

Explore the Evidence

The sections below provide the complete evidence questions, supporting relationships, and underlying studies behind the summary above.

Questions Answered by the Evidence

What outcomes has Insulin Therapies been studied for?

outcomes studied

Emerging Evidence

HbA1c, Glucose iAUC (OGTT), and Hypoglycemia events are among the most studied areas in relation to Insulin Therapies.

ConsistencyScore™: Consistency cannot yet be determined from the available evidence.

Evidence caveat: The evidence includes both beneficial and harmful or worsening results.

Ranked evidence signals

1
HbA1c
EvidenceScore™ Strong | EvidenceScore™ 79.0 | strong positive | ConsistencyScore™ Consistent | 13 studies
2
Glucose iAUC (OGTT)
EvidenceScore™ Strong | EvidenceScore™ 79.0 | moderate positive | ConsistencyScore™ Generally Consistent | 3 studies
3
Hypoglycemia events
EvidenceScore™ Strong | EvidenceScore™ 79.0 | weak positive | ConsistencyScore™ Mixed | 4 studies

Why this answer: This answer is cautious because the available studies report mixed findings.

Limitations

Consistency cannot yet be determined.
Population details are unavailable.

Does Insulin Therapies improve HbA1c?

intervention outcome_effect

Strong Evidence

Insulin Therapies may improve HbA1c.

ConsistencyScore™: Results are consistent across studies.

Ranked evidence signals

1
HbA1c
EvidenceScore™ Strong | EvidenceScore™ 79.0 | strong positive | ConsistencyScore™ Consistent | 13 studies

Why this answer: This answer is based on 13 supporting studies with consistent results and a positive effect signal.

Limitations

Population details are unavailable.

Which outcomes have the strongest evidence for Insulin Therapies?

evidence strength

Strong Evidence

HbA1c, Glucose iAUC (OGTT), and Hypoglycemia events have the strongest available evidence signals for Insulin Therapies.

ConsistencyScore™: Results are consistent across studies.

Evidence caveat: The evidence includes both beneficial and harmful or worsening results.

Ranked evidence signals

1
HbA1c
EvidenceScore™ Strong | EvidenceScore™ 79.0 | strong positive | ConsistencyScore™ Consistent | 13 studies
2
Glucose iAUC (OGTT)
EvidenceScore™ Strong | EvidenceScore™ 79.0 | moderate positive | ConsistencyScore™ Generally Consistent | 3 studies
3
Hypoglycemia events
EvidenceScore™ Strong | EvidenceScore™ 79.0 | weak positive | ConsistencyScore™ Mixed | 4 studies

Why this answer: This answer is cautious because the available studies report mixed findings.

Limitations

Population details are unavailable.

Where does Insulin Therapies need more research?

research gaps

Moderate Evidence

Percentage of blood glucose measurements within target range of 3.9–7.8 mmol/L, Time to glycemic target, and Mean glucose from rtCGM need more research in relation to Insulin Therapies.

ConsistencyScore™: Results are mixed and should be interpreted cautiously.

Evidence caveat: The evidence includes both beneficial and harmful or worsening results.

Ranked evidence signals

1
Percentage of blood glucose measurements within target range of 3.9–7.8 mmol/L
EvidenceScore™ Moderate | EvidenceScore™ 69.0 | strong positive | ConsistencyScore™ Consistent | 2 studies
2
Time to glycemic target
EvidenceScore™ Moderate | EvidenceScore™ 69.0 | strong positive | ConsistencyScore™ Mixed | 2 studies
3
Time above range
EvidenceScore™ Moderate | EvidenceScore™ 69.0 | moderate positive | ConsistencyScore™ Mixed | 2 studies

Why this answer: This answer is cautious because the available studies report mixed findings.

Limitations

Population details are unavailable.

How does Insulin Therapies compare across studied outcomes?

cross outcome_comparison

Strong Evidence

HbA1c, Glucose iAUC (OGTT), and Hypoglycemia events have available evidence for Insulin Therapies, but the comparison requires review of the underlying studies.

ConsistencyScore™: Results are consistent across studies.

Evidence caveat: The evidence includes both beneficial and harmful or worsening results.

Ranked evidence signals

1
HbA1c
EvidenceScore™ Strong | EvidenceScore™ 79.0 | strong positive | ConsistencyScore™ Consistent | 13 studies
2
Glucose iAUC (OGTT)
EvidenceScore™ Strong | EvidenceScore™ 79.0 | moderate positive | ConsistencyScore™ Generally Consistent | 3 studies
3
Hypoglycemia events
EvidenceScore™ Strong | EvidenceScore™ 79.0 | weak positive | ConsistencyScore™ Mixed | 4 studies

Why this answer: This answer is cautious because the available studies report mixed findings.

Limitations

Population details are unavailable.

Evidence summary for AI and search

Among 23 indexed studies and 4 interventions, the strongest signals are summarized from the available evidence. HbA1c appears to be one of the clearer current evidence signals.